Prakash et al., 2021 - Google Patents
Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical updatePrakash et al., 2021
View HTML- Document ID
- 13933730656293012395
- Author
- Prakash K
- Chandorkar A
- Saharia K
- Publication year
- Publication venue
- Diagnostics
External Links
Snippet
Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ transplant (SOT) recipients. However, current techniques used to predict risk for CMV infection fall short. CMV-specific cell mediated immunity (CMI) plays an important role in …
- 210000000056 organs 0 title abstract description 50
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prakash et al. | Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update | |
| Hassouneh et al. | Functional changes of T-cell subsets with age and CMV infection | |
| Mouton et al. | Torque teno virus viral load as a marker of immune function in allogeneic haematopoietic stem cell transplantation recipients | |
| Clémenceau et al. | SARS-CoV-2 T-cell responses in allogeneic hematopoietic stem cell recipients following two doses of BNT162b2 mRNA vaccine | |
| Kuczaj et al. | Torque teno virus (TTV)—a potential marker of immunocompetence in solid organ recipients | |
| Gliga et al. | Comparison of three cellular assays to predict the course of CMV infection in liver transplant recipients | |
| Reuter et al. | Neutralizing antibodies limit cell-associated spread of human cytomegalovirus in epithelial cells and fibroblasts | |
| El-Mokhtar et al. | Hepatitis C virus affects tuberculosis-specific T cells in HIV-negative patients | |
| Gandolfo et al. | Overview of anti-SARS-CoV-2 immune response six months after BNT162b2 mRNA vaccine | |
| Ouellette | Adoptive immunotherapy for prophylaxis and treatment of cytomegalovirus infection | |
| Engelmann et al. | Prevention and management of CMV infections after liver transplantation: current practice in German transplant centers | |
| Waters et al. | The detection of CMV in saliva can mark a systemic infection with CMV in renal transplant recipients | |
| França et al. | Epidemiology of the epstein–barr virus in autoimmune inflammatory rheumatic diseases in northern Brazil | |
| Bonavita et al. | Don’t go breaking my heart: MCMV as a model for HCMV-associated cardiovascular diseases | |
| Paolini et al. | Patients recovering from severe COVID-19 develop a polyfunctional antigen-specific CD4+ T cell response | |
| Ciabattini et al. | Trajectory of spike-specific B cells elicited by two doses of BNT162b2 mRNA vaccine | |
| Koldehoff et al. | Long-term follow-up after adoptive transfer of BK-virus-specific T cells in hematopoietic stem cell transplant recipients | |
| Tomaszewski et al. | Overexpression of PD-1 on peripheral blood lymphocytes in patients with idiopathic pulmonary arterial hypertension and its association with high viral loads of Epstein-Barr virus and poor clinical parameters | |
| Albert et al. | Torque teno virus DNA load in blood as an immune status biomarker in adult hematological patients: the state of the art and future prospects | |
| Mendoza et al. | Polyomaviruses after allogeneic hematopoietic stem cell transplantation | |
| Gupta et al. | Cytomegalovirus infections in hematopoietic stem cell transplant: moving beyond molecular diagnostics to immunodiagnostics | |
| Maple et al. | Cytomegalovirus, Epstein-Barr virus, herpes simplex virus, and varicella zoster virus infection dynamics in people with multiple sclerosis from Northern Italy | |
| Li et al. | Prospects of cytomegalovirus-specific T-Cell receptors in clinical diagnosis and therapy | |
| Wagner et al. | Breakthrough infections in SARS-coV-2-vaccinated multiple myeloma patients improve cross-protection against omicron variants | |
| Lupo et al. | High predictive value of the soluble ZEBRA antigen (Epstein-Barr virus trans-activator Zta) in transplant patients with PTLD |